Open Access

Real‑world study of Cerviron® vaginal ovules in the treatment of cervical lesions of various etiologies

  • Authors:
    • Izabella Petre
    • Daniela Teodora Sirbu
    • Ramona Petrita
    • Andreea-Denisa Toma
    • Ema Peta
    • Florentina Dimcevici‑Poesina
  • View Affiliations

  • Published online on: July 7, 2023     https://doi.org/10.3892/br.2023.1618
  • Article Number: 54
  • Copyright: © Petre et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical lesions can be caused by pathogens, hormonal changes or by cervical injury. The recommended treatment in all cases is excision. Local re‑epithelialization therapy should be initiated preoperatively and postoperatively. The present study assessed the post‑market performance and tolerability of Cerviron® ovules in the treatment and management of cervical lesions postoperatively. The study population included 345 participants aged 20‑70 years with either a cervical lesion under treatment or with recent surgical removal of a cervical lesion. The degree of re‑epithelialization of the cervical mucosa was improved in 73.17% of the patients evaluated during routine colposcopy exams and 92.73% of patients recorded no bleeding. When adding Cerviron® either as monotherapy or in association with other antimicrobials in postoperative care of the cervical ectropion, improved postoperative outcomes such as reduced post‑interventional bleeding and a superior quality of healing were observed. The study and its details are registered in www.clinicaltrials.gov under ID NCT05668806.
View Figures
View References

Related Articles

Journal Cover

August-2023
Volume 19 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Petre I, Sirbu DT, Petrita R, Toma A, Peta E and Dimcevici‑Poesina F: Real‑world study of Cerviron<sup>®</sup> vaginal ovules in the treatment of cervical lesions of various etiologies. Biomed Rep 19: 54, 2023
APA
Petre, I., Sirbu, D.T., Petrita, R., Toma, A., Peta, E., & Dimcevici‑Poesina, F. (2023). Real‑world study of Cerviron<sup>®</sup> vaginal ovules in the treatment of cervical lesions of various etiologies. Biomedical Reports, 19, 54. https://doi.org/10.3892/br.2023.1618
MLA
Petre, I., Sirbu, D. T., Petrita, R., Toma, A., Peta, E., Dimcevici‑Poesina, F."Real‑world study of Cerviron<sup>®</sup> vaginal ovules in the treatment of cervical lesions of various etiologies". Biomedical Reports 19.2 (2023): 54.
Chicago
Petre, I., Sirbu, D. T., Petrita, R., Toma, A., Peta, E., Dimcevici‑Poesina, F."Real‑world study of Cerviron<sup>®</sup> vaginal ovules in the treatment of cervical lesions of various etiologies". Biomedical Reports 19, no. 2 (2023): 54. https://doi.org/10.3892/br.2023.1618